[1]
|
Tenzer, A. and Pruschy, M. (2003) Potentiation of DNAdamage-induced cytotoxicity by G2checkpoint abrogators. Current Medicinal Chemistry—Anti-Cancer Agents, 3, 35-46. doi:10.2174/1568011033353533
|
[2]
|
Lehman, T.A., Bennett, W.P., Metcalf, R.A., Welsh, J.A., Ecker, J., Modali, R.V., Ullrich, S., Romano, J.W., Appella, E. and Testa, J.R. (1991) p53 mutations, ras mutations, and p53-heat shock 70 protein complexes in human lung carcinoma cell lines. Cancer Research, 51, 40904096.
|
[3]
|
Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991) Participation of p53 protein in the cellular response to DNA damage. Cancer Research, 51, 6304-6311
|
[4]
|
Lee, J.M. and Bernstein, A. (1995) Apoptosis, cancer and the p53 tumour suppressor gene. Cancer and Metastasis Reviews, 14, 149-161. doi:10.1007/BF00665797
|
[5]
|
Serafin, A.M., Akudugu, J.M. and Böhm, L. (2003) Studies on the influence of DNA repair on radio-sensitivity in prostate cell lines. Urological Research, 31, 227231. doi:10.1007/s00240-003-0299-0
|
[6]
|
Katsuro, T. and Hiroyuki, T. (1989) Caffeine enhancement of the effect of anticancer agents on human sarcoma cells. Cancer Science, 80, 83-88.
doi:10.1111/j.1349-7006.1989.tb02249.x
|
[7]
|
Saito, Y., Gopalan, B., Mhashilkar, A.M., Roth, J.A., Chada, S., Zumstein, L. and Ramesh, R. (2003) Adenovirus-mediated PTEN treatment combined with caffeine produces a synergistic therapeutic effect in colorectal cancer cells. Cancer Gene Therapy, 10, 803-813.
doi:10.1038/sj.cgt.7700644
|
[8]
|
Maity, A., Kao, G.D., Muschel, R.J. and McKenna, W.G. (1997) Potential molecular targets for manipulating the radiation response. International Journal of Radiation Oncology, Biology, Physics, 37, 639-653.
doi:10.1016/S0360-3016(96)00598-6
|
[9]
|
Zhu, W.Y. and Melera, P.W. (2001) Levels of metallothionein I and II expression in mouse embryo broblasts enhance growth in low folate through a cell cycle mediated pathway. Cell Biology, 21, 1261.
|
[10]
|
Russell, K.J., Wiens, L.W., Demers, G.W., Galloway, D.A., Plon, S.E. and Groudine, M. (1995) Abrogation of the G2 checkpoint results in differential radiosensitization of G1 checkpoint-deficient and G1 checkpoint-competent cells. Cancer Research, 55, 1639-1642.
doi:10.1016/0360-3016(95)97826-M
|
[11]
|
Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P. and Vaigro-Wolff, A. (1991) Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. Journal of the National Cancer Institute, 83, 757-766. doi:10.1093/jnci/83.11.757
|
[12]
|
Siu, W.Y., Yam, C.H. and Poon, R.Y. (1999) G1 versus G2 cell cycle arrest after adriamycin-induced damage in mouse Swiss3T3 cells. FEBS Letters, 461, 299-305.
doi:10.1016/S0014-5793(99)01481-7
|
[13]
|
Bode, A.M. and Dong, Z. (2007) The enigmatic effects of caffeine in cell cycle and cancer. Cancer Letters, 247, 2639. doi:10.1016/j.canlet.2006.03.032
|